-
Administration of sterile viable Trichuris suis eggs to patients with active Crohns disease led to impressive clinical improvement.
-
In selected patients with community-acquired pneumonia, outpatient treatment with levofloxacin was as safe and effective as hospitalization.
-
Solifenacin succinate has been approved for the treatment of overactive bladder, the third new agent to be approved for this indication in the last 7 months.
-
The lead II rhythm strip shown in the Figure was taken from a patient in atrial flutter. Although difficult to see due to artifact in the baseline, an underlying sawtooth pattern is nevertheless present. In addition, there is something distinctly unusual about this example of atrial flutter. What is it? What clinical diagnosis is suggested as a possible cause of this ECG finding?
-
Stopping aspirin may be hazardous to your health, according to recent research.
-
A standardized work-up will reveal a cause for drop attacks, which are sudden collapse without loss of consciousness, in 90% of cases.
-
Contradicting previous studies, no evidence was found in a large review of cancer patients that deaths were postponed relative to significant life events.
-
Clinicians share a common goal in respect to early diagnosis and treatment of colon cancer, yet the optimum pathway with which to reach this goal is controversial.
-
Sildenafil Citrate for Erectile Dysfunction in Men Receiving Multiple Antihypertensive Agents, Risk of Fracture after Androgen Deprivation for Prostate Cancer, Chronic Stress Accelerates Ultraviolet-Induced Cutaneous Carcinogenesis, Air Contrast Barium Enema, CT Colonography, and Colonoscopy, Risk Stratification for In-Hospital Mortality in Acutely Decompensated Heart Failure, Obesity, Weight Gain, and the Risk of Kidney Stones.
-
The CDC published its first recommendations for management of exposure to HIV in the occupational setting in 1990, at a time when the only available antiretroviral was zidvudine. They first addressed the issue of non-occupational exposure in print in 1998, at which time they, however, concluded that the available evidence for or against post-exposure prophylaxis (PEP) in this setting was inadequate to allow them to make a recommendation applicable to the United States.
